Semmax Financial Advisors Inc. Amgen Inc Transaction History

Semmax Financial Advisors Inc.

$320 Million
Q2 2024

A detailed history of Semmax Financial Advisors Inc. transactions in Amgen Inc stock. As of the latest transaction made, Semmax Financial Advisors Inc. holds 10,662 shares of AMGN stock, worth $3.37 Million. This represents 1.04% of its overall portfolio holdings.

Number of Shares

10,662

Previous 11,216 4.94%

Holding current value

$3.37 Million

Previous $3.19 Million 4.49%

% of portfolio

1.04%

Previous 1.07%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$262.75 - $319.31 $145,563 - $176,897	-554 Reduced 4.94%	10,662 $3.33 Million
Q1 2024 May 16, 2024	SELL	$268.87 - $324.56 $209,180 - $252,507	-778 Reduced 6.49%	11,216 $3.19 Million
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $313,488 - $353,651	-1,226 Reduced 9.27%	11,994 $3.45 Million
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $336,502 - $417,776	-1,539 Reduced 10.43%	13,220 $3.55 Million
Q4 2022 Feb 09, 2023	SELL	$229.03 - $291.01 $21,528 - $27,354	-94 Reduced 0.63%	14,759 $3.98 Million
Q3 2022 Nov 15, 2022	BUY	$224.46 - $253.15 $239,723 - $270,364	1,068 Added 7.75%	14,853 $4.12 Million
Q2 2022 Aug 12, 2022	BUY	$230.71 - $256.74 $303,383 - $337,613	1,315 Added 10.55%	13,785 $3.48 Million
Q1 2022 May 11, 2022	BUY	$219.27 - $242.57 $216,858 - $239,901	989 Added 8.61%	12,470 $3.02 Million
Q4 2021 Mar 01, 2022	SELL	$198.88 - $227.6 $193,510 - $221,454	-973 Reduced 7.81%	11,481 $2.58 Million
Q3 2021 Nov 10, 2021	SELL	$212.27 - $248.7 $228,827 - $268,098	-1,078 Reduced 7.97%	12,454 $2.65 Million
Q2 2021 Aug 11, 2021	BUY	$233.58 - $259.14 $84,555 - $93,808	362 Added 2.75%	13,532 $3.3 Million
Q1 2021 May 04, 2021	BUY	$221.91 - $258.6 $73,008 - $85,079	329 Added 2.56%	13,170 $3.28 Million
Q4 2020 Feb 05, 2021	BUY	$216.38 - $257.67 $102,131 - $121,620	472 Added 3.82%	12,841 $2.95 Million
Q3 2020 Oct 29, 2020	BUY	$234.65 - $260.95 $121,783 - $135,433	519 Added 4.38%	12,369 $3.14 Million
Q2 2020 Jul 17, 2020	BUY	$197.81 - $242.74 $333,507 - $409,259	1,686 Added 16.59%	11,850 $2.8 Million
Q1 2020 May 05, 2020	BUY	$182.24 - $241.7 $261,878 - $347,322	1,437 Added 16.47%	10,164 $2.06 Million
Q4 2019 Feb 03, 2020	SELL	$189.21 - $243.2 $156,855 - $201,612	-829 Reduced 8.68%	8,727 $2.1 Million
Q3 2019 Nov 07, 2019	BUY	$174.11 - $208.62 $198,311 - $237,618	1,139 Added 13.53%	9,556 $1.85 Million
Q2 2019 Aug 07, 2019	BUY	$166.7 - $195.41 $738,647 - $865,861	4,431 Added 111.16%	8,417 $1.55 Million
Q1 2019 May 07, 2019	BUY	$180.87 - $203.88 $371,868 - $419,177	2,056 Added 106.53%	3,986 $757,000
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $344,312 - $401,922	1,930 New	1,930 $376,000

Others Institutions Holding AMGN

# of Institutions

3,073

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Semmax Financial Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on Semmax Financial Advisors Inc. with notifications on news.

Account

Semmax Financial Advisors Inc. Amgen Inc Transaction History